Transthoracic biopsies under fluoro-computer tomography (CT) guidance play an important role on the diagnosis and management of lung nodules, permitting histological examination and differentiation between benign and malignant lesions(1). Furthermore, with recent advances in target therapy, it is increasingly necessary to obtain tumor tissue for the analysis of molecular fingerprints allowing personalized treatment(1). Although many studies report low complication rates for this procedure, they are not negligible, urging the need for a structured and reproducible guide to reduce technique-related complications(1,2).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.48729/pjctvs.223 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!